Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
Current management of relapsing-remitting multiple sclerosis.
The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis.
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo.
Jean-Martin Charcot, father of modern neurology: an homage 120 years after his death.
Regulatory dendritic cell therapy: From rodents to clinical application.
Study of fatigue frequency and its association with sociodemographic and clinical variables in patients with multiple sclerosis.
Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis.
Risk Factors for Suicidal Ideation in Patients Feeling Severely Affected by Multiple Sclerosis.
Three Minor Diterpenoids with Three Carbon Skeletons from Euphorbia peplus.
Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying.
Myeloid cell-based therapies in neurological disorders: How far have we come?
Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.
Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder.
Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.
Identifying physical activity information needs and preferred methods of delivery of people with multiple sclerosis.
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.
Dietary Sutherlandia and Elderberry Mitigate Cerebral Ischemia-Induced Neuronal Damage and Attenuate p47phox and Phospho-ERK1/2 Expression in Microglial Cells.
Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
471
472
473
474
475
476
477
478
479
…
next ›
last »